Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Opiant Pharmaceuticals In...

    NASDAQ: OPNT · Real-Time Price · USD
    20.65
    0.00 (0.00%)
    At close: Mar 01, 2023, 10:00 PM

    Opiant Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2021
    Period Ending Dec 31, 2021
    Revenue
    		 40.73M
    Cost of Revenue
    		 9.07M
    Gross Profit
    		 31.66M
    Operating Income
    		 5.16M
    Interest Income
    		 11.4K
    Pretax Income
    		 3.03M
    Net Income
    		 3.01M
    Selling & General & Admin
    		 16.73M
    Research & Development
    		 16.83M
    Other Expenses
    		 -7.06M
    Operating Expenses
    		 26.5M
    Interest Expense
    		 2.13M
    Selling & Marketing Expenses
    		 4.58M
    Cost & Expenses
    		 35.57M
    Income Tax Expense
    		 24.27K
    Shares Outstanding (Basic)
    		 4.46M
    Shares Outstanding (Diluted)
    		 5.92M
    EPS (Basic)
    		 0.68
    EPS (Diluted)
    		 0.51
    EBITDA
    		 5.83M
    EBIT
    		 5.16M
    Depreciation & Amortization
    		 661.53K

    Add to Watchlist